This page shows the details of why an item matched the keywords from your search.
Item Type | Name |
Concept
|
Odds Ratio
|
Academic Article
|
Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis.
|
Academic Article
|
Vaccination history and risk of non-Hodgkin lymphoma: a population-based, case-control study.
|
Academic Article
|
Obesity and risk of non-Hodgkin lymphoma (United States).
|
Academic Article
|
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.
|
Academic Article
|
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.
|
Academic Article
|
Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies.
|
Academic Article
|
Alcohol consumption, family history of hematolymphoproliferative cancer, and the risk of non-Hodgkin's lymphoma in men.
|
Academic Article
|
Changes in diet during adult life and risk of colorectal adenomas.
|
Academic Article
|
Dietary nitrate and nitrite intake and risk of non-Hodgkin lymphoma.
|
Academic Article
|
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
|
Academic Article
|
Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa.
|
Academic Article
|
Obesity and immigration among Latina women.
|
Academic Article
|
Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
|
Academic Article
|
Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium.
|
Academic Article
|
Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.
|
Academic Article
|
Targets of biologic disease-modifying antirheumatic drugs and risk of multiple myeloma.
|
Academic Article
|
Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma.
|